Ontology highlight
ABSTRACT: Introduction
Chronic non-malignant pain has a major impact on the well-being, mood and productivity of those affected. Opioids are increasingly prescribed to manage this type of pain, but with a risk of other disabling symptoms, when their effectiveness has been questioned. This trial is designed to implement and evaluate a patient-centred intervention targeting withdrawal of strong opioids in people with chronic pain.Methods and analysis
A pragmatic, multicentre, randomised controlled trial will assess the clinical and cost-effectiveness of a group-based multicomponent intervention combined with individualised clinical facilitator led support for the management of chronic non-malignant pain against the control intervention (self-help booklet and relaxation compact disc). An embedded process evaluation will examine fidelity of delivery and investigate experiences of the intervention. The two primary outcomes are activities of daily living (measured by Patient-Reported Outcomes Measurement Information System Pain Interference Short Form (8A)) and opioid use. The secondary outcomes are pain severity, quality of life, sleep quality, self-efficacy, adverse events and National Health Service (NHS) healthcare resource use. Participants are followed up at 4, 8 and 12 months, with a primary endpoint of 12 months. Between-group differences will indicate effectiveness; we are looking for a difference of 3.5 points on our pain interference outcome (scale 40 to 77). We will undertake an NHS perspective cost-effectiveness analysis using quality adjusted life years.Ethics and dissemination
Full approval was given by Yorkshire & The Humber - South Yorkshire Research Ethics Committee on 13 September, 2016 (16/YH/0325). Appropriate local approvals were sought for each area in which recruitment was undertaken. The current protocol version is 1.6 date 19 December 2018. Publication of results in peer- reviewed journals will inform the scientific and clinical community. We will disseminate results to patient participants and study facilitators in a study newsletter as well as a lay summary of results on the study website.Trial registration number
ISRCTN49470934; Pre-results.
SUBMITTER: Sandhu HK
PROVIDER: S-EPMC6701652 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
Sandhu Harbinder K HK Abraham Charles C Alleyne Sharisse S Balasubramanian Shyam S Betteley Lauren L Booth Katie K Carnes Dawn D Furlan Andrea D AD Haywood Kirstie K Iglesias Urrutia Cynthia Paola CP Lall Ranjit R Manca Andrea A Mistry Dipesh D Nichols Vivien P VP Noyes Jennifer J Rahman Anisur A Seers Kate K Shaw Jane J Tang Nicole K Y NKY Taylor Stephanie S Tysall Colin C Underwood Martin M Withers Emma J EJ Eldabe Sam S
BMJ open 20190808 8
<h4>Introduction</h4>Chronic non-malignant pain has a major impact on the well-being, mood and productivity of those affected. Opioids are increasingly prescribed to manage this type of pain, but with a risk of other disabling symptoms, when their effectiveness has been questioned. This trial is designed to implement and evaluate a patient-centred intervention targeting withdrawal of strong opioids in people with chronic pain.<h4>Methods and analysis</h4>A pragmatic, multicentre, randomised cont ...[more]